Answer
Intracranial hypertension during mecasermin (Increlex) treatment has been reported with papilloedema, visual changes, headache, nausea and/or vomiting.
Sources for this answer
- Increlex 10 mg/ml solution for injectionEsteve Pharmaceuticals (formerly Intrapharm Laboratories) · emc · SmPC §4.4 Special warnings and precautions for use · Version 2Document updated
Sources checked